Summary

The patient monitoring devices market is projected to reach USD 76.11 billion by 2031, up from USD 55.60 billion in 2026, at a CAGR of 6.4%.

Continuous technological innovation and increasing adoption of connected healthcare technologies are significantly driving growth in the patient monitoring devices market. Advancements in patient monitoring systems, including wearable devices, continuous glucose monitoring (CGM), remote patient monitoring platforms, and AI-enabled analytics, offer real-time health tracking, improved clinical decision-making, and enhanced patient outcomes. These technologies support continuous monitoring, reduce dependence on hospitals, and enable early detection of health deterioration. Additionally, innovations in device design have led to compact, wireless, and user-friendly systems, making them more suitable for hospital and home-care settings. Manufacturers are increasingly integrating smart features such as cloud connectivity, mobile applications, predictive analytics, and telehealth compatibility. This ongoing innovation cycle is accelerating the replacement of traditional monitoring systems and driving sustained global demand for advanced patient monitoring devices.

Based on product: The patient monitoring devices market includes multiparameter monitors, blood glucose monitoring devices (CGM and SMBG), wearable monitoring devices, EEG, EMG, ICP, ECG, ILR, MCT, pulse oximeters, fetal & neonatal monitors, blood pressure monitoring devices, hemodynamic monitoring systems, spirometers, and capnography devices. Among these, blood glucose monitoring devices, particularly continuous glucose monitoring (CGM) systems, represent a major growth-driving subsegment. The dominance of this segment is driven primarily by the rising global prevalence of diabetes and the growing need for continuous disease management. CGM and wearable glucose monitoring devices provide real-time glucose insights that support timely treatment decisions and improve patient outcomes. Strong adoption across hospitals, clinics, and home care settings, coupled with rising demand for preventive healthcare, home-based monitoring, smartphone connectivity, and connected healthcare platforms, continues to strengthen the market position of blood glucose monitoring devices.

Based on end user: Hospitals and clinics account for the largest share of the patient monitoring devices market due to their central role in managing acute and chronic conditions requiring continuous patient surveillance. These facilities routinely utilize patient monitoring systems across general wards, intensive care units (ICUs), and emergency & trauma centers to track critical parameters such as heart rate, blood pressure, oxygen saturation, and glucose levels. The growing prevalence of cardiovascular diseases, diabetes, and respiratory disorders has significantly increased demand for real-time monitoring and early clinical intervention. Additionally, hospitals and clinics benefit from advanced healthcare infrastructure, skilled professionals, and integration of connected monitoring technologies. Ongoing investments in critical care capabilities and digital healthcare solutions further drive the adoption of patient monitoring devices, reinforcing the dominance of hospitals and clinics in the market.

North America’s well-developed healthcare infrastructure plays a crucial role in supporting the widespread adoption of patient monitoring devices. The region has an extensive network of hospitals, specialty clinics, and advanced care facilities equipped with modern monitoring technologies to efficiently manage acute and chronic conditions. Healthcare systems across the US and Canada are characterized by strong clinical protocols, high healthcare spending, and highly trained professionals, enabling seamless integration of patient monitoring solutions into routine care. Additionally, the growing adoption of continuous glucose monitoring systems, cardiac monitoring devices, wearable technologies, and remote patient monitoring platforms supports early diagnosis and timely intervention. Regular investments in digital health technologies and continuous upgrades of monitoring systems further contribute to sustained demand. The presence of a robust healthcare ecosystem ensures consistent utilization and adoption of patient monitoring devices across multiple care settings.
A breakdown of the primary respondents (supply-side) for the patient monitoring devices market referred to in this report is provided below:
・ By Company Type: Tier 1: 40%, Tier 2: 30%, and Tier 3: 30%
・ By Designation: C-level: 55%, Director Level: 27%, and Others: 18%
・ By Region: North America: 34%, Europe: 27%, Asia Pacific: 30%, Latin America: 6%, Middle East & Africa: 2% and GCC Countries: 2%
Prominent players in the patient monitoring devices market include Medtronic Plc (Ireland), Abbott Laboratories (US), Dexcom, Inc. (US), GE HealthCare (US), Philips Healthcare (Netherlands), Nihon Kohden Corporation (Japan), Mindray Medical International Ltd. (China), Edwards Lifesciences Corporation (US), Getinge AB (Sweden), Baxter International Inc. (US), Drägerwerk AG & Co. KGaA (Germany), Boston Scientific Corporation (US), Masimo Corporation (US), Omron Corporation (Japan), ARCHIMED SAS (Natus Medical) (France), Compumedics Limited (Australia), and Nonin Medical, Inc. (US), among others.

Research Coverage
The report evaluates the patient monitoring devices market and estimates the market size and future growth potential of this market based on various segments, including product, end user, and region. The report also includes a competitive analysis of the major players in this market, along with company profiles, product offerings, recent developments, and key market strategies.
Reasons to Buy the Report
The report will assist market leaders and new entrants in the patient monitoring devices market with data on the nearest approximations of revenue figures for the overall market and its subsegments. The report will help stakeholders understand the competitive landscape and gain insights to better position their businesses and develop effective go-to-market strategies. It also enables stakeholders to understand market dynamics and provides insights into key drivers, restraints, challenges, and growth opportunities influencing the patient monitoring devices market.
This report provides insights into the following points:
・ Analysis of key drivers (rising prevalence of chronic diseases such as diabetes and cardiovascular disorders, growing aging population requiring continuous monitoring and long-term healthcare management, increasing demand for remote patient monitoring and home healthcare solutions, rapid adoption of wearable and connected healthcare technologies, technological advancements in AI-enabled and cloud-integrated monitoring systems), restraints (high cost of advanced monitoring systems, data privacy and cybersecurity concerns, stringent regulatory approval requirements for medical devices), opportunities (expansion of remote patient monitoring platforms, development of low-cost and portable monitoring devices, growing adoption of home-based and preventive healthcare solutions), and challenges (limited healthcare infrastructure in developing regions, interoperability issues across connected monitoring platforms, reimbursement and adoption barriers in emerging markets)
・ Product Enhancement/Innovation: Comprehensive details about product launches and anticipated trends in the global patient monitoring devices market.
・ Market Development: Thorough knowledge and analysis of the profitable rising markets by product, end user, and region.
・ Market Diversification: Comprehensive information about newly launched products, expanding markets, current advancements, and investments in the global patient monitoring devices market
・ Competitive Assessment: Thorough evaluation of the market shares, growth plans, offerings, and capacities of the major competitors in the global patient monitoring devices market

ページTOPに戻る

Table of Contents

1 INTRODUCTION 36
1.1 STUDY OBJECTIVES 36
1.2 MARKET DEFINITION 36
1.3 STUDY SCOPE 37
1.3.1 MARKETS COVERED 37
1.3.2 INCLUSIONS AND EXCLUSIONS 38
1.3.3 YEARS CONSIDERED 38
1.3.4 CURRENCY CONSIDERED 39
1.4 STAKEHOLDERS 39
1.5 SUMMARY OF CHANGES 40
2 EXECUTIVE SUMMARY 41
2.1 KEY INSIGHTS AND MARKET HIGHLIGHTS 41
2.2 KEY MARKET PARTICIPANTS: SHARE INSIGHTS AND START DEVELOPMENTS 43
2.3 DISRUPTIVE TRENDS SHAPING MARKET 44
2.4 HIGH-GROWTH SEGMENTS & EMERGING FRONTIERS 45
2.5 SNAPSHOT: GLOBAL MARKET SIZE, GROWTH RATE, AND FORECAST 46
3 PREMIUM INSIGHTS 47
3.1 PATIENT MONITORING DEVICES MARKET OVERVIEW 47
3.2 NORTH AMERICA: PATIENT MONITORING DEVICES MARKET, BY PRODUCT AND COUNTRY (2025) 48
3.3 PATIENT MONITORING DEVICES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 49
3.4 PATIENT MONITORING DEVICES MARKET, BY REGION (2024–2031) 50
3.5 PATIENT MONITORING DEVICES MARKET: DEVELOPED MARKETS VS. EMERGING ECONOMIES 50
4 MARKET OVERVIEW 51
4.1 INTRODUCTION 51
4.2 MARKET DYNAMICS 51
4.2.1 DRIVERS 52
4.2.1.1 Emergence of predictive analytics in vital sign monitors 52
4.2.1.2 Growing preference for wearable patient monitoring devices, biosensors, and smart implants 53
4.2.1.3 Availability of wireless monitoring devices 53
4.2.1.4 Expansion of telehealth services and remote monitoring capabilities 54
4.2.1.5 Growing incidence of chronic diseases 54
 
4.2.2 RESTRAINTS 56
4.2.2.1 Risks associated with invasive monitoring devices 56
4.2.2.2 High cost of patient monitoring products and inadequate reimbursement 56
4.2.3 OPPORTUNITIES 57
4.2.3.1 Integration with electronic health records (EHRs) 57
4.2.3.2 Expansion of remote patient monitoring in home healthcare settings 58
4.2.4 CHALLENGES 58
4.2.4.1 Lack of personnel and limited awareness & education for patient monitoring devices 58
4.2.4.2 Increased pricing pressure on market players 59
4.3 UNMET NEEDS AND WHITE SPACES 60
4.3.1 UNMET NEEDS IN PATIENT MONITORING DEVICES MARKET 60
4.3.2 WHITE SPACE OPPORTUNITIES 61
4.4 INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES 62
4.4.1 INTERCONNECTED MARKETS 62
4.4.2 CROSS-SECTOR OPPORTUNITIES 62
4.5 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS 63
5 INDUSTRY TRENDS 64
5.1 PORTER’S FIVE FORCES ANALYSIS 64
5.1.1 THREAT OF NEW ENTRANTS 65
5.1.2 THREAT OF SUBSTITUTES 65
5.1.3 BARGAINING POWER OF SUPPLIERS 66
5.1.4 BARGAINING POWER OF BUYERS 66
5.1.5 INTENSITY OF COMPETITIVE RIVALRY 66
5.2 MACROECONOMIC OUTLOOK 66
5.2.1 INTRODUCTION 66
5.2.2 GDP TRENDS AND FORECAST 66
5.2.3 TRENDS IN GLOBAL PATIENT MONITORING DEVICES INDUSTRY 68
5.2.4 TRENDS IN GLOBAL HEALTHCARE & MEDICAL DEVICES INDUSTRY 68
5.3 SUPPLY CHAIN ANALYSIS 69
5.3.1 PROMINENT COMPANIES 69
5.3.2 SMALL & MEDIUM-SIZED COMPANIES 69
5.3.3 END USERS 69
5.4 VALUE CHAIN ANALYSIS 70
5.4.1 RESEARCH & DEVELOPMENT 70
5.4.2 PROCUREMENT AND PRODUCT DEVELOPMENT 70
5.4.3 MARKETING, SALES, DISTRIBUTION, AND POST-SALES SERVICES 70
5.5 ECOSYSTEM ANALYSIS 71
5.6 PRICING ANALYSIS 72
5.6.1 AVERAGE SELLING PRICE, BY PRODUCT (2025) 72
5.6.2 AVERAGE SELLING PRICE, BY REGION (2025) 73
5.7 TRADE ANALYSIS 75
5.7.1 IMPORT SCENARIO (HS CODE 9018) 76
5.7.2 EXPORT DATA (HS CODE 9018) 76
5.8 KEY CONFERENCES AND EVENTS, 2026–2027 77
5.9 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 78
5.10 INVESTMENT AND FUNDING SCENARIO 79
5.11 CASE STUDY ANALYSIS 79
5.11.1 CASE STUDY 1: SCALING REMOTE CARDIAC MONITORING 79
5.11.2 CASE STUDY 2: IMPROVING CHRONIC DISEASE MANAGEMENT THROUGH RPM 80
5.11.3 CASE STUDY 3: ENHANCING PATIENT SURVEILLANCE IN ACUTE CARE SETTINGS 80
5.12 IMPACT OF US TARIFFS—PATIENT MONITORING DEVICES MARKET 80
5.12.1 INTRODUCTION 80
5.12.2 KEY TARIFF RATES 81
5.12.3 PRICE IMPACT ANALYSIS 82
5.12.4 IMPACT ON COUNTRIES/REGIONS 83
5.12.4.1 North America 83
5.12.4.2 Europe 83
5.12.4.3 Asia Pacific 83
5.12.5 IMPACT ON END-USE INDUSTRIES 83
6 TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS 85
6.1 KEY EMERGING TECHNOLOGIES 85
6.1.1 SMART WEARABLE MONITORING DEVICES 85
6.1.2 VITAL SIGN MONITORS 85
6.2 COMPLEMENTARY TECHNOLOGIES 86
6.2.1 REMOTE PATIENT MONITORS 86
6.2.2 AI & IOT 86
6.3 TECHNOLOGY/PRODUCT ROADMAP 87
6.3.1 SHORT-TERM (2025–2027) | FOUNDATION & EARLY COMMERCIALIZATION 87
6.3.2 MID-TERM (2027–2030) | EXPANSION & STANDARDIZATION 87
6.3.3 LONG-TERM (2030–2035+) | MASS COMMERCIALIZATION & DISRUPTION 88
6.4 PATENT ANALYSIS 89
6.4.1 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS 90
6.5 FUTURE APPLICATIONS 90
6.5.1 AI-ENABLED REMOTE PATIENT MONITORING & PREDICTIVE HEALTH ANALYTICS 91
6.5.2 HOME-BASED CHRONIC DISEASE MANAGEMENT & TELEHEALTH INTEGRATION 91
6.5.3 SMART HOSPITALS & INTEGRATED CLINICAL MONITORING NETWORKS 91
 
6.6 IMPACT OF AI/GEN AI ON PATIENT MONITORING DEVICES MARKET 92
6.6.1 TOP USE CASES AND MARKET POTENTIAL 92
6.6.2 CASE STUDIES OF AI IMPLEMENTATION IN PATIENT MONITORING DEVICES MARKET 93
6.6.3 INTERCONNECTED/ADJACENT ECOSYSTEMS AND IMPACT ON MARKET PLAYERS 93
6.6.4 CLIENTS’ READINESS TO ADOPT GENERATIVE AI IN PATIENT MONITORING DEVICES MARKET 94
7 REGULATORY LANDSCAPE 95
7.1 REGIONAL REGULATIONS AND COMPLIANCE 95
7.1.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 95
7.1.2 INDUSTRY STANDARDS 99
8 CUSTOMER LANDSCAPE & BUYER BEHAVIOR 100
8.1 DECISION-MAKING PROCESS 100
8.2 BUYER STAKEHOLDERS AND BUYING EVALUATION CRITERIA 100
8.2.1 KEY STAKEHOLDERS IN BUYING PROCESS 100
8.2.2 KEY BUYING CRITERIA 101
8.3 ADOPTION BARRIERS & INTERNAL CHALLENGES 102
8.4 UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES 102
8.5 MARKET PROFITABILITY 103
8.5.1 REVENUE POTENTIAL 103
8.5.2 COST DYNAMICS 103
8.5.3 MARGIN OPPORTUNITIES IN KEY APPLICATIONS 104
9 PATIENT MONITORING DEVICES MARKET, BY PRODUCT 105
9.1 INTRODUCTION 106
9.2 BLOOD GLUCOSE MONITORING DEVICES 107
9.2.1 SELF-MONITORING BLOOD GLUCOSE DEVICES 108
9.2.1.1 Rising adoption of integrated glucose monitoring devices to drive growth 108
9.2.2 CONTINUOUS GLUCOSE MONITORING DEVICES 110
9.2.2.1 Product launches and evolving reimbursement scenarios for continuous monitoring devices to drive market growth 110
9.2.3 WEARABLE GLUCOSE MONITORING DEVICES 112
9.2.3.1 Growing patient inclination towards wearable monitors to boost the market 112
9.3 CARDIAC MONITORING DEVICES 113
9.3.1 ECG DEVICES 115
9.3.1.1 Low cost and wide applications of ECG devices to drive market growth 115
9.3.2 IMPLANTABLE LOOP RECORDERS 117
9.3.2.1 High cost and limited applications to limit growth 117
9.3.3 EVENT MONITORS 118
9.3.3.1 Emergence of portable and wireless event monitors to drive market growth 118
9.3.4 MCT MONITORS 119
9.3.4.1 Availability of alternate technologies to hinder market growth 119
9.3.5 SMART/WEARABLE ECG MONITORS 121
9.3.5.1 Need to minimize treatment costs for CVD patients to increase adoption of smart/wearable ECG monitors 121
9.4 MULTIPARAMETER MONITORING DEVICES 123
9.4.1 LOW-ACUITY MONITORS 125
9.4.1.1 Increasing adoption of low-acuity monitors in general wards to drive market growth 125
9.4.2 MID-ACUITY MONITORS 126
9.4.2.1 Rising geriatric population to increase market growth 126
9.4.3 HIGH-ACUITY MONITORS 127
9.4.3.1 Increasing partnerships between manufacturers and hospitals & clinics to drive device sales 127
9.5 RESPIRATORY MONITORING DEVICES 128
9.5.1 PULSE OXIMETERS 130
9.5.1.1 Rising adoption of pulse oximeters in home care settings to drive market growth 130
9.5.2 SPIROMETERS 131
9.5.2.1 Technological advancements to increase adoption of spirometers 131
9.5.3 CAPNOGRAPHS 133
9.5.3.1 Product development and growing commercial acceptance to drive market growth 133
9.5.4 PEAK FLOW METERS 134
9.5.4.1 Low preference for peak flow meters due to high variability in measurements from different devices, to hinder market growth 134
9.6 TEMPERATURE MONITORING DEVICES 136
9.6.1 HANDHELD TEMPERATURE MONITORING DEVICES 137
9.6.1.1 Advantages associated with handheld temperature monitoring devices to drive market growth 137
9.6.2 TABLE-TOP TEMPERATURE MONITORING DEVICES 139
9.6.2.1 Increasing risks associated with hypothermia during surgeries to drive demand for table-top devices 139
9.6.3 WEARABLE CONTINUOUS MONITORING DEVICES 141
9.6.3.1 Versatile functionalities offered by wearable continuous monitoring devices to drive demand 141
9.6.4 INVASIVE TEMPERATURE MONITORING DEVICES 142
9.6.4.1 Risk of bloodstream infections associated with catheter usage to hinder market for invasive devices 142
9.6.5 SMART TEMPERATURE MONITORING PATCHES 144
9.6.5.1 Long-term monitoring capabilities of smart patches to drive market growth 144
 
9.7 HEMODYNAMIC/PRESSURE MONITORING DEVICES 146
9.7.1 HEMODYNAMIC MONITORS 147
9.7.1.1 Influx of VC funding to drive market growth 147
9.7.2 BLOOD PRESSURE MONITORS 149
9.7.2.1 Development of wearable blood pressure monitors to drive market growth 149
9.7.3 DISPOSABLES 150
9.7.3.1 Growing number of surgical procedures to drive growth in disposables market 150
9.8 FETAL & NEONATAL MONITORING DEVICES 151
9.8.1 FETAL MONITORING DEVICES 153
9.8.1.1 Rising prevalence of obstetric complications to drive market growth 153
9.8.2 NEONATAL MONITORING DEVICES 155
9.8.2.1 Rising number of neonatal care facilities worldwide to drive market 155
9.9 NEUROMONITORING DEVICES 157
9.9.1 EEG MACHINES 158
9.9.1.1 Growing applications and technological advancements to favor market growth 158
9.9.2 EMG MACHINES 160
9.9.2.1 Availability of reimbursements for EMG-assisted surgeries to boost product demand 160
9.9.3 CEREBRAL OXIMETERS 161
9.9.3.1 Growing cases of hypoxia during surgical procedures to drive market growth 161
9.9.4 ICP MONITORS 163
9.9.4.1 Growing incidence of post-surgical cerebrovascular complications and TBIs to support adoption of ICP monitors 163
9.9.5 MEG MACHINES 164
9.9.5.1 High implementation and maintenance costs of MEG devices hinder market growth 164
9.9.6 TCD MACHINES 165
9.9.6.1 Rising prevalence of strokes and cerebrovascular disorders to contribute to market growth 165
9.10 WEIGHT MONITORING DEVICES 167
9.10.1 DIGITAL WEIGHT MONITORING DEVICES 168
9.10.1.1 Consumer preference for digital scales—a key market driver 168
9.10.2 ANALOG WEIGHT MONITORING DEVICES 170
9.10.2.1 Rising prevalence of obesity and low cost of analog scales to support market growth 170
9.11 OTHER PATIENT MONITORING DEVICES 171
 
10 PATIENT MONITORING DEVICES MARKET, BY END USER 174
10.1 INTRODUCTION 175
10.2 HOSPITALS & CLINICS 175
10.2.1 ABILITY TO AFFORD HIGH INSTALLATION & MAINTENANCE COSTS OF PATIENT MONITORING TECHNOLOGIES TO BOOST MARKET 175
10.3 AMBULATORY SURGICAL CENTERS 177
10.3.1 COST-EFFECTIVENESS AND CONVENIENCE TO DRIVE DEMAND FOR AMBULATORY CARE 177
10.4 HOME CARE SETTINGS 178
10.4.1 REDUCED COST AND CONTINUOUS MONITORING OF VITAL INFORMATION IN HOME SETTINGS TO BOOST GROWTH 178
10.5 OTHER END USERS 179
11 PATIENT MONITORING DEVICES MARKET, BY REGION 181
11.1 INTRODUCTION 182
11.2 NORTH AMERICA 183
11.2.1 US 189
11.2.1.1 Growing number of FDA approvals for patient monitoring devices to support market growth 189
11.2.2 CANADA 196
11.2.2.1 Growing public-private funding for research to drive market growth 196
11.3 EUROPE 204
11.3.1 GERMANY 210
11.3.1.1 Rising healthcare expenditure and manufacturer expansion to boost market growth 210
11.3.2 UK 216
11.3.2.1 Increasing public & private investments to contribute to market growth 216
11.3.3 FRANCE 222
11.3.3.1 Statutory health insurance system to support market growth 222
11.3.4 ITALY 228
11.3.4.1 Rising incidence of lifestyle diseases to drive adoption of patient monitoring devices 228
11.3.5 SPAIN 234
11.3.5.1 Growing number of surgical procedures to drive market growth in Spain 234
11.3.6 REST OF EUROPE 240
11.4 ASIA PACIFIC 246
11.4.1 JAPAN 253
11.4.1.1 Large geriatric population and favorable reimbursement scenario to support market growth 253
11.4.2 CHINA 259
11.4.2.1 Growing focus of local and international market players to favor market growth 259
 
11.4.3 INDIA 265
11.4.3.1 Increasing government-implemented healthcare initiatives to support market growth 265
11.4.4 AUSTRALIA 271
11.4.4.1 R&D tax incentive program to support market growth 271
11.4.5 SOUTH KOREA 277
11.4.5.1 Supportive government initiatives to drive market growth 277
11.4.6 REST OF ASIA PACIFIC 283
11.5 LATIN AMERICA 290
11.5.1 BRAZIL 296
11.5.1.1 Brazil to dominate LATAM market 296
11.5.2 MEXICO 302
11.5.2.1 Favorable investment scenario for medical device manufacturers to drive market growth 302
11.5.3 REST OF LATIN AMERICA 308
11.6 MIDDLE EAST & AFRICA 315
11.6.1 AWARENESS INITIATIVES TO DRIVE ADOPTION OF PATIENT MONITORING DEVICES 315
11.7 GCC COUNTRIES 321
11.7.1 HEALTHCARE DIGITALIZATION INITIATIVES TO ACCELERATE PATIENT MONITORING DEVICE ADOPTION IN GCC 321
12 COMPETITIVE LANDSCAPE 328
12.1 OVERVIEW 328
12.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 328
12.3 REVENUE ANALYSIS 329
12.4 MARKET SHARE ANALYSIS 330
12.4.1 GLOBAL BLOOD GLUCOSE MONITORING DEVICES MARKET SHARE,
BY KEY PLAYER, 2025 330
12.4.2 GLOBAL CARDIAC MONITORING DEVICES MARKET SHARE, BY KEY PLAYER, 2025 331
12.4.3 GLOBAL MULTIPARAMETER MONITORING DEVICES MARKET SHARE,
BY KEY PLAYER, 2025 332
12.4.4 GLOBAL HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET SHARE, BY KEY PLAYER, 2025 332
12.4.5 GLOBAL FETAL & NEONATAL MONITORING DEVICES MARKET SHARE,
BY KEY PLAYER, 2025 333
12.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025 335
12.5.1 STARS 335
12.5.2 EMERGING LEADERS 335
12.5.3 PERVASIVE PLAYERS 335
12.5.4 PARTICIPANTS 335
12.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2025 337
12.5.5.1 Company footprint 337
12.5.5.2 Region footprint 338
12.5.5.3 Product footprint 339
12.5.5.4 End-user footprint 340
12.6 COMPETITIVE EVALUATION MATRIX: STARTUPS/SMES, 2025 341
12.6.1 PROGRESSIVE COMPANIES 341
12.6.2 RESPONSIVE COMPANIES 341
12.6.3 DYNAMIC COMPANIES 341
12.6.4 STARTING BLOCKS 341
12.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2025 343
12.6.5.1 Detailed list of key startups/SMEs 343
12.6.5.2 Competitive benchmarking of key startups/SMEs, 2025 344
12.7 COMPANY VALUATION & FINANCIAL METRICS 345
12.8 BRAND/PRODUCT COMPARISON 346
12.9 COMPETITIVE SCENARIO 347
12.9.1 PRODUCT LAUNCHES & APPROVALS 347
12.9.2 DEALS 347
12.9.3 EXPANSIONS 348
13 COMPANY PROFILES 349
13.1 KEY PLAYERS 349
13.1.1 MEDTRONIC 349
13.1.1.1 Business overview 349
13.1.1.2 Products offered 350
13.1.1.3 Recent developments 353
13.1.1.3.1 Product launches & approvals 353
13.1.1.3.2 Deals 354
13.1.1.4 MnM view 355
13.1.1.4.1 Right to win 355
13.1.1.4.2 Strategic choices 355
13.1.1.4.3 Weaknesses and competitive threats 355
13.1.2 ABBOTT LABORATORIES 356
13.1.2.1 Business overview 356
13.1.2.2 Products offered 357
13.1.2.3 Recent developments 358
13.1.2.3.1 Product launches & approvals 358
13.1.2.3.2 Deals 360
13.1.2.4 MnM view 360
13.1.2.4.1 Right to win 360
13.1.2.4.2 Strategic choices 360
13.1.2.4.3 Weaknesses & competitive threats 361
 
13.1.3 DEXCOM, INC. 362
13.1.3.1 Business overview 362
13.1.3.2 Products offered 363
13.1.3.3 Recent developments 364
13.1.3.3.1 Product launches & approvals 364
13.1.3.3.2 Deals 364
13.1.3.4 MnM view 365
13.1.3.4.1 Right to win 365
13.1.3.4.2 Strategic choices 365
13.1.3.4.3 Weaknesses & competitive threats 365
13.1.4 GE HEALTHCARE 366
13.1.4.1 Business overview 366
13.1.4.2 Products offered 367
13.1.4.3 Recent developments 369
13.1.4.3.1 Product launches & approvals 369
13.1.4.3.2 Deals 369
13.1.4.4 MnM view 370
13.1.4.4.1 Right to win 370
13.1.4.4.2 Strategic choices 370
13.1.4.4.3 Weaknesses & competitive threats 370
13.1.5 PHILIPS HEALTHCARE 371
13.1.5.1 Business overview 371
13.1.5.2 Products offered 372
13.1.5.3 Recent developments 375
13.1.5.3.1 Product launches & approvals 375
13.1.5.3.2 Deals 375
13.1.5.4 MnM view 377
13.1.5.4.1 Right to win 377
13.1.5.4.2 Strategic choices 377
13.1.5.4.3 Weaknesses & competitive threats 377
13.1.6 NIHON KOHDEN CORPORATION 378
13.1.6.1 Business overview 378
13.1.6.2 Products offered 379
13.1.6.3 Recent developments 381
13.1.6.3.1 Product launches & approvals 381
13.1.6.3.2 Deals 381
13.1.7 MINDRAY MEDICAL INTERNATIONAL LTD. 383
13.1.7.1 Business overview 383
13.1.7.2 Products offered 384
13.1.7.3 Recent developments 385
13.1.7.3.1 Product launches & approvals 385
13.1.7.3.2 Deals 386
13.1.8 BD 387
13.1.8.1 Business overview 387
13.1.8.2 Products offered 388
13.1.9 GETINGE AB 390
13.1.9.1 Business overview 390
13.1.9.2 Products offered 391
13.1.9.3 Recent developments 392
13.1.9.3.1 Product launches, enhancements, and approvals 392
13.1.9.3.2 Deals 393
13.1.10 BAXTER INTERNATIONAL (HILL-ROM HOLDINGS, INC.) 394
13.1.10.1 Business overview 394
13.1.10.2 Products offered 395
13.1.11 DRÄGERWERK AG & CO. KGAA 398
13.1.11.1 Business overview 398
13.1.11.2 Products offered 399
13.1.12 BOSTON SCIENTIFIC CORPORATION 402
13.1.12.1 Business overview 402
13.1.12.2 Products offered 403
13.1.12.3 Recent developments 404
13.1.12.3.1 Deals 404
13.1.13 MASIMO CORPORATION 405
13.1.13.1 Business overview 405
13.1.13.2 Products offered 406
13.1.14 OMRON CORPORATION 410
13.1.14.1 Business overview 410
13.1.14.2 Products offered 411
13.1.15 ARCHIMED SAS (NATUS MEDICAL) 415
13.1.15.1 Business overview 415
13.1.15.2 Products offered 415
13.1.15.3 Recent developments 416
13.1.15.3.1 Deals 416
13.1.16 COMPUMEDICS LIMITED 417
13.1.16.1 Business overview 417
13.1.16.2 Products offered 418
13.1.16.3 Recent developments 419
13.1.16.3.1 Deals 419
13.1.17 NONIN MEDICAL, INC. 420
13.1.17.1 Business overview 420
13.1.17.2 Products offered 420
13.1.17.3 Recent developments 421
13.1.17.3.1 Product launches & approvals 421
 
13.2 OTHER PLAYERS 422
13.2.1 BIOTRONIK 422
13.2.2 SCHILLER AG 422
13.2.3 SENSEONICS 424
13.2.4 CARDIOMO 424
13.2.5 VITLS 425
13.2.6 NETEERA 425
13.2.7 QARDIO 426
13.2.8 VIVIFY HEALTH 426
13.2.9 IRHYTHM TECHNOLOGIES, INC. 427
13.2.10 OSYPKA MEDICAL 427
13.2.11 CARDINAL HEALTH 428
13.2.12 MERIT MEDICAL SYSTEMS 429
14 RESEARCH METHODOLOGY 430
14.1 RESEARCH DATA 430
14.1.1 SECONDARY DATA 431
14.1.1.1 Key data from secondary sources 432
14.1.2 PRIMARY DATA 433
14.1.2.1 Key data from primary sources 434
14.1.2.2 Key industry insights 434
14.2 MARKET SIZE ESTIMATION 436
14.3 MARKET BREAKDOWN AND DATA TRIANGULATION 441
14.4 MARKET SHARE ESTIMATION 442
14.5 STUDY ASSUMPTIONS 442
14.6 METHODOLOGY-RELATED LIMITATIONS 442
14.7 RESEARCH LIMITATIONS 442
14.8 RISK ASSESSMENT 443
15 APPENDIX 444
15.1 DISCUSSION GUIDE 444
15.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 449
15.3 CUSTOMIZATION OPTIONS 451
15.4 RELATED REPORTS 451
15.5 AUTHOR DETAILS 452

ページTOPに戻る

List of Tables/Graphs

TABLE 1 STANDARD CURRENCY CONVERSION RATES TO USD 39
TABLE 2 PATIENT MONITORING MARKET: PORTER’S FIVE FORCES ANALYSIS 64
TABLE 3 GDP PERCENTAGE CHANGE, BY KEY COUNTRY, 2021-2030 67
TABLE 4 AVERAGE SELLING PRICE OF PATIENT MONITORING DEVICES, BY KEY PLAYER, 2025 (USD) 73
TABLE 5 AVERAGE SELLING PRICE OF PATIENT MONITORING DEVICES, BY REGION,
2025 (USD) 74
TABLE 6 IMPORT DATA FOR PATIENT MONITORING DEVICES PRODUCTS UNDER HS CODE 9018, BY COUNTRY, 2021–2025 (USD THOUSAND) 76
TABLE 7 EXPORT DATA FOR PATIENT MONITORING DEVICES UNDER HS CODE 9018,
BY COUNTRY, 2021–2025 (USD THOUSAND) 77
TABLE 8 PATIENT MONITORING DEVICES MARKET: DETAILED LIST OF KEY CONFERENCES AND EVENTS (2026-2027) 77
TABLE 9 US-ADJUSTED RECIPROCAL TARIFF RATES 81
TABLE 10 KEY PRODUCT-RELATED TARIFF EFFECTIVE FOR PATIENT MONITORING DEVICES 82
TABLE 11 TOP USE CASES AND MARKET POTENTIAL 92
TABLE 12 PATIENT MONITORING DEVICES MARKET: CASE STUDIES RELATED
TO AI IMPLEMENTATION 93
TABLE 13 INTERCONNECTED/ADJACENT ECOSYSTEM AND IMPACT ON MARKET PLAYERS 93
TABLE 14 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 95
TABLE 15 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 96
TABLE 16 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 97
TABLE 17 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 98
TABLE 18 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 98
TABLE 19 GLOBAL STANDARDS IN PATIENT MONITORING DEVICES MARKET 99
TABLE 20 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS OF PATIENT MONITORING DEVICES 101
TABLE 21 KEY BUYING CRITERIA FOR PATIENT MONITORING DEVICES 102
TABLE 22 PATIENT MONITORING DEVICES MARKET: UNMET NEEDS/END-USER EXPECTATIONS 102
TABLE 23 PATIENT MONITORING DEVICES MARKET, BY PRODUCT,
2024–2031 (USD MILLION) 106
TABLE 24 BLOOD GLUCOSE MONITORING DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 107
TABLE 25 BLOOD GLUCOSE MONITORING DEVICES MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 107
TABLE 26 PATIENT MONITORING DEVICES MARKET VOLUME FOR BLOOD GLUCOSE MONITORING DEVICES, BY REGION, 2024–2031 (UNITS) 108
TABLE 27 SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 110
TABLE 28 CONTINUOUS GLUCOSE MONITORING DEVICES MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 111
TABLE 29 WEARABLE GLUCOSE MONITORING DEVICES MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 112
TABLE 30 CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 113
TABLE 31 CARDIAC MONITORING DEVICES MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 114
TABLE 32 PATIENT MONITORING DEVICES MARKET VOLUME FOR CARDIAC MONITORING DEVICES, BY REGION, 2024–2031 (UNITS) 115
TABLE 33 ECG DEVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 116
TABLE 34 IMPLANTABLE LOOP RECORDERS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 117
TABLE 35 EVENT MONITORS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 119
TABLE 36 MCT MONITORS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 120
TABLE 37 SMART/WEARABLE ECG MONITORS OFFERED BY MARKET PLAYERS 121
TABLE 38 SMART/WEARABLE ECG MONITORS MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 122
TABLE 39 MULTIPARAMETER MONITORING DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 123
TABLE 40 MULTIPARAMETER MONITORING DEVICES MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 124
TABLE 41 PATIENT MONITORING DEVICES MARKET VOLUME FOR MULTI-PARAMETER MONITORING DEVICES, BY REGION, 2024–2031 (UNITS) 125
TABLE 42 LOW-ACUITY MONITORS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 125
TABLE 43 MID-ACUITY MONITORS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 126
TABLE 44 HIGH-ACUITY MONITORS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 127
TABLE 45 RESPIRATORY MONITORING DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 128
TABLE 46 RESPIRATORY MONITORING DEVICES MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 129
TABLE 47 PATIENT MONITORING DEVICES MARKET VOLUME FOR RESPIRATORY MONITORING DEVICES, BY REGION, 2024–2031 (UNITS) 130
TABLE 48 PULSE OXIMETERS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 131
TABLE 49 SPIROMETERS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 132
TABLE 50 CAPNOGRAPHS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 134
TABLE 51 PEAK FLOW METERS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 135
TABLE 52 TEMPERATURE MONITORING DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 136
TABLE 53 TEMPERATURE MONITORING DEVICES MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 136
TABLE 54 PATIENT MONITORING DEVICES MARKET VOLUME FOR TEMPERATURE MONITORING SYSTEMS, BY REGION, 2024–2031 (UNITS) 137
TABLE 55 HANDHELD TEMPERATURE MONITORING DEVICES OFFERED BY MARKET PLAYERS 138
TABLE 56 HANDHELD TEMPERATURE MONITORING DEVICES MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 139
TABLE 57 TABLE-TOP TEMPERATURE MONITORING DEVICES MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 140
TABLE 58 WEARABLE CONTINUOUS MONITORING DEVICES OFFERED BY MARKET PLAYERS 141
TABLE 59 WEARABLE CONTINUOUS MONITORING DEVICES MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 142
TABLE 60 INVASIVE TEMPERATURE MONITORING DEVICES MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 143
TABLE 61 SMART TEMPERATURE MONITORING PATCHES OFFERED BY MARKET PLAYERS 144
TABLE 62 SMART TEMPERATURE MONITORING PATCHES MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 145
TABLE 63 HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 146
TABLE 64 HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 146
TABLE 65 PATIENT MONITORING DEVICES MARKET VOLUME FOR HEMODYNAMIC/
PRESSURE MONITORING DEVICES, BY REGION, 2024–2031 (UNITS) 147
TABLE 66 HEMODYNAMIC MONITORS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 148
TABLE 67 WEARABLE BLOOD PRESSURE MONITORS OFFERED BY MARKET PLAYERS 149
TABLE 68 BLOOD PRESSURE MONITORS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 150
TABLE 69 HEMODYNAMIC/PRESSURE MONITORING DISPOSABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 151
TABLE 70 FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 152
TABLE 71 FETAL & NEONATAL MONITORING DEVICES MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 152
TABLE 72 PATIENT MONITORING DEVICES MARKET VOLUME FOR FETAL & NEONATAL MONITORING DEVICES, BY REGION, 2024–2031 (UNITS) 153
TABLE 73 WEARABLE FETAL MONITORING & OBSTETRIC DEVICES OFFERED
BY MARKET PLAYERS 154
TABLE 74 FETAL MONITORING DEVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 155
TABLE 75 NEONATAL MONITORING DEVICES MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 156
TABLE 76 NEUROMONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 157
TABLE 77 NEUROMONITORING DEVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 157
TABLE 78 PATIENT MONITORING DEVICES MARKET VOLUME FOR NEUROMONITORING DEVICES, BY REGION, 2024–2031 (UNITS) 158
TABLE 79 EEG MACHINES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 159
TABLE 80 EMG MACHINES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 161
TABLE 81 CEREBRAL OXIMETERS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 162
TABLE 82 ICP MONITORS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 163
TABLE 83 MEG MACHINES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 165
TABLE 84 TCD MACHINES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 166
TABLE 85 WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 167
TABLE 86 WEIGHT MONITORING DEVICES MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 167
TABLE 87 PATIENT MONITORING DEVICES MARKET VOLUME FOR WEIGHT MONITORING DEVICES, BY REGION, 2024–2031 (UNITS) 168
TABLE 88 DIGITAL WEIGHT MONITORING DEVICES MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 169
TABLE 89 ANALOG WEIGHT MONITORING DEVICES MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 170
TABLE 90 POLYSOMNOGRAPHY DEVICES OFFERED BY VARIOUS PLAYERS 171
TABLE 91 WEARABLE SLEEP MONITORING DEVICES OFFERED BY MARKET PLAYERS 172
TABLE 92 OTHER PATIENT MONITORING DEVICES MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 173
TABLE 93 PATIENT MONITORING DEVICES MARKET, BY END USER,
2024–2031 (USD MILLION) 175
TABLE 94 PATIENT MONITORING DEVICES MARKET FOR HOSPITALS & CLINICS, BY TYPE, 2024–2031 (USD MILLION) 176
TABLE 95 PATIENT MONITORING DEVICES MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2024–2031 (USD MILLION) 176
TABLE 96 PATIENT MONITORING DEVICES MARKET FOR AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2024–2031 (USD MILLION) 177
TABLE 97 PATIENT MONITORING DEVICES MARKET FOR HOME CARE SETTINGS,
BY COUNTRY, 2024–2031 (USD MILLION) 179
TABLE 98 PATIENT MONITORING DEVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2024–2031 (USD MILLION) 180
TABLE 99 PATIENT MONITORING DEVICES MARKET, BY REGION, 2024–2031 (USD MILLION) 182
TABLE 100 NORTH AMERICA: PATIENT MONITORING DEVICES MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 184
TABLE 101 NORTH AMERICA: PATIENT MONITORING DEVICES MARKET, BY PRODUCT,
2024–2031 (USD MILLION) 184
TABLE 102 NORTH AMERICA: BLOOD GLUCOSE MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 185
TABLE 103 NORTH AMERICA: CARDIAC MONITORING DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 185
TABLE 104 NORTH AMERICA: MULTIPARAMETER MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 186
TABLE 105 NORTH AMERICA: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 186
TABLE 106 NORTH AMERICA: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 187
TABLE 107 NORTH AMERICA: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET,
BY TYPE, 2024–2031 (USD MILLION) 187
TABLE 108 NORTH AMERICA: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 188
TABLE 109 NORTH AMERICA: NEUROMONITORING DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 188
TABLE 110 NORTH AMERICA: WEIGHT MONITORING DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 189
TABLE 111 NORTH AMERICA: PATIENT MONITORING DEVICES MARKET, BY END USER,
2024–2031 (USD MILLION) 189
TABLE 112 US: VC FUNDING IN PATIENT MONITORING DEVICES MARKET 190
TABLE 113 US: PATIENT MONITORING DEVICES MARKET, BY PRODUCT,
2024–2031 (USD MILLION) 191
TABLE 114 US: BLOOD GLUCOSE MONITORING DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 191
TABLE 115 US: CARDIAC MONITORING DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 192
TABLE 116 US: MULTIPARAMETER MONITORING DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 192
TABLE 117 US: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 193
TABLE 118 US: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 193
TABLE 119 US: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 194
TABLE 120 US: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 194
TABLE 121 US: NEUROMONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 195
TABLE 122 US: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 195
TABLE 123 US: PATIENT MONITORING DEVICES MARKET, BY END USER,
2024–2031 (USD MILLION) 196
TABLE 124 RESEARCH GRANTS IN PATIENT MONITORING DEVICES MARKET IN CANADA 197
TABLE 125 RECENT DEVELOPMENTS IN CANADIAN PATIENT MONITORING DEVICES MARKET 197
TABLE 126 CANADA: PATIENT MONITORING DEVICES MARKET, BY PRODUCT,
2024–2031 (USD MILLION) 198
TABLE 127 CANADA: BLOOD GLUCOSE MONITORING DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 199
TABLE 128 CANADA: CARDIAC MONITORING DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 199
TABLE 129 CANADA: MULTIPARAMETER MONITORING DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 200
TABLE 130 CANADA: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 200
TABLE 131 CANADA: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 201
TABLE 132 CANADA: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 201
TABLE 133 CANADA: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 202
TABLE 134 CANADA: NEUROMONITORING DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 202
TABLE 135 CANADA: WEIGHT MONITORING DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 203
TABLE 136 CANADA: PATIENT MONITORING DEVICES MARKET, BY END USER,
2024–2031 (USD MILLION) 203
TABLE 137 PRODUCT APPROVALS IN EUROPEAN PATIENT MONITORING DEVICES MARKET 204
TABLE 138 EUROPE: PATIENT MONITORING DEVICES MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 205
TABLE 139 EUROPE: PATIENT MONITORING DEVICES MARKET, BY PRODUCT,
2024–2031 (USD MILLION) 205
TABLE 140 EUROPE: BLOOD GLUCOSE MONITORING DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 206
TABLE 141 EUROPE: CARDIAC MONITORING DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 206
TABLE 142 EUROPE: MULTIPARAMETER MONITORING DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 207
TABLE 143 EUROPE: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 207
TABLE 144 EUROPE: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 208
TABLE 145 EUROPE: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 208
TABLE 146 EUROPE: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 209
TABLE 147 EUROPE: NEUROMONITORING DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 209
TABLE 148 EUROPE: WEIGHT MONITORING DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 210
TABLE 149 EUROPE: PATIENT MONITORING DEVICES MARKET, BY END USER,
2024–2031 (USD MILLION) 210
TABLE 150 GERMANY: PATIENT MONITORING DEVICES MARKET, BY PRODUCT,
2024–2031 (USD MILLION) 211
TABLE 151 GERMANY: BLOOD GLUCOSE MONITORING DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 211
TABLE 152 GERMANY: CARDIAC MONITORING DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 212
TABLE 153 GERMANY: MULTIPARAMETER MONITORING DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 212
TABLE 154 GERMANY: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 213
TABLE 155 GERMANY: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 213
TABLE 156 GERMANY: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 214
TABLE 157 GERMANY: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 214
TABLE 158 GERMANY: NEUROMONITORING DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 215
TABLE 159 GERMANY: WEIGHT MONITORING DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 215
TABLE 160 GERMANY: PATIENT MONITORING DEVICES MARKET, BY END USER,
2024–2031 (USD MILLION) 216
TABLE 161 UK: PATIENT MONITORING DEVICES MARKET, BY PRODUCT,
2024–2031 (USD MILLION) 217
TABLE 162 UK: BLOOD GLUCOSE MONITORING DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 217
TABLE 163 UK: CARDIAC MONITORING DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 218
TABLE 164 UK: MULTIPARAMETER MONITORING DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 218
TABLE 165 UK: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 219
TABLE 166 UK: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 219
TABLE 167 UK: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 220
TABLE 168 UK: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 220
TABLE 169 UK: NEUROMONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 221
TABLE 170 UK: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 221
TABLE 171 UK: PATIENT MONITORING DEVICES MARKET, BY END USER,
2024–2031 (USD MILLION) 222
TABLE 172 FRANCE: PATIENT MONITORING DEVICES MARKET, BY PRODUCT,
2024–2031 (USD MILLION) 223
TABLE 173 FRANCE: BLOOD GLUCOSE MONITORING DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 223
TABLE 174 FRANCE: CARDIAC MONITORING DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 224
TABLE 175 FRANCE: MULTIPARAMETER MONITORING DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 224
TABLE 176 FRANCE: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 225
TABLE 177 FRANCE: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 225
TABLE 178 FRANCE: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 226
TABLE 179 FRANCE: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 226
TABLE 180 FRANCE: NEUROMONITORING DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 227
TABLE 181 FRANCE: WEIGHT MONITORING DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 227
TABLE 182 FRANCE: PATIENT MONITORING DEVICES MARKET, BY END USER,
2024–2031 (USD MILLION) 228
TABLE 183 ITALY: PATIENT MONITORING DEVICES MARKET, BY PRODUCT,
2024–2031 (USD MILLION) 229
TABLE 184 ITALY: BLOOD GLUCOSE MONITORING DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 229
TABLE 185 ITALY: CARDIAC MONITORING DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 230
TABLE 186 ITALY: MULTIPARAMETER MONITORING DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 230
TABLE 187 ITALY: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 231
TABLE 188 ITALY: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 231
TABLE 189 ITALY: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 232
TABLE 190 ITALY: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 232
TABLE 191 ITALY: NEUROMONITORING DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 233
TABLE 192 ITALY: WEIGHT MONITORING DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 233
TABLE 193 ITALY: PATIENT MONITORING DEVICES MARKET, BY END USER,
2024–2031 (USD MILLION) 234
TABLE 194 SPAIN: PATIENT MONITORING DEVICES MARKET, BY PRODUCT,
2024–2031 (USD MILLION) 235
TABLE 195 SPAIN: BLOOD GLUCOSE MONITORING DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 235
TABLE 196 SPAIN: CARDIAC MONITORING DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 236
TABLE 197 SPAIN: MULTIPARAMETER MONITORING DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 236
TABLE 198 SPAIN: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 237
TABLE 199 SPAIN: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 237
TABLE 200 SPAIN: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 238
TABLE 201 SPAIN: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 238
TABLE 202 SPAIN: NEUROMONITORING DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 239
TABLE 203 SPAIN: WEIGHT MONITORING DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 239
TABLE 204 SPAIN: PATIENT MONITORING DEVICES MARKET, BY END USER,
2024–2031 (USD MILLION) 240
TABLE 205 REST OF EUROPE: PATIENT MONITORING DEVICES MARKET, BY PRODUCT,
2024–2031 (USD MILLION) 241
TABLE 206 REST OF EUROPE: BLOOD GLUCOSE MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 241
TABLE 207 REST OF EUROPE: CARDIAC MONITORING DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 242
TABLE 208 REST OF EUROPE: MULTIPARAMETER MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 242
TABLE 209 REST OF EUROPE: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 243
TABLE 210 REST OF EUROPE: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 243
TABLE 211 REST OF EUROPE: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET,
BY TYPE, 2024–2031 (USD MILLION) 244
TABLE 212 REST OF EUROPE: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 244
TABLE 213 REST OF EUROPE: NEUROMONITORING DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 245
TABLE 214 REST OF EUROPE: WEIGHT MONITORING DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 245
TABLE 215 REST OF EUROPE: PATIENT MONITORING DEVICES MARKET, BY END USER,
2024–2031 (USD MILLION) 246
TABLE 216 ASIA PACIFIC: PATIENT MONITORING DEVICES MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 248
TABLE 217 ASIA PACIFIC: PATIENT MONITORING DEVICES MARKET, BY PRODUCT,
2024–2031 (USD MILLION) 248
TABLE 218 ASIA PACIFIC: BLOOD GLUCOSE MONITORING DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 249
TABLE 219 ASIA PACIFIC: CARDIAC MONITORING DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 249
TABLE 220 ASIA PACIFIC: MULTIPARAMETER MONITORING DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 250
TABLE 221 ASIA PACIFIC: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 250
TABLE 222 ASIA PACIFIC: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 251
TABLE 223 ASIA PACIFIC: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET,
BY TYPE, 2024–2031 (USD MILLION) 251
TABLE 224 ASIA PACIFIC: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 252
TABLE 225 ASIA PACIFIC: NEUROMONITORING DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 252
TABLE 226 ASIA PACIFIC: WEIGHT MONITORING DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 253
TABLE 227 ASIA PACIFIC: PATIENT MONITORING DEVICES MARKET, BY END USER,
2024–2031 (USD MILLION) 253
TABLE 228 JAPAN: PATIENT MONITORING DEVICES MARKET, BY PRODUCT,
2024–2031 (USD MILLION) 254
TABLE 229 JAPAN: BLOOD GLUCOSE MONITORING DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 255
TABLE 230 JAPAN: CARDIAC MONITORING DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 255
TABLE 231 JAPAN: MULTIPARAMETER MONITORING DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 256
TABLE 232 JAPAN: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 256
TABLE 233 JAPAN: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 257
TABLE 234 JAPAN: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 257
TABLE 235 JAPAN: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 258
TABLE 236 JAPAN: NEUROMONITORING DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 258
TABLE 237 JAPAN: WEIGHT MONITORING DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 259
TABLE 238 JAPAN: PATIENT MONITORING DEVICES MARKET, BY END USER,
2024–2031 (USD MILLION) 259
TABLE 239 CHINA: PATIENT MONITORING DEVICES MARKET, BY PRODUCT,
2024–2031 (USD MILLION) 260
TABLE 240 CHINA: BLOOD GLUCOSE MONITORING DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 261
TABLE 241 CHINA: CARDIAC MONITORING DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 261
TABLE 242 CHINA: MULTIPARAMETER MONITORING DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 262
TABLE 243 CHINA: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 262
TABLE 244 CHINA: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 263
TABLE 245 CHINA: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 263
TABLE 246 CHINA: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 264
TABLE 247 CHINA: NEUROMONITORING DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 264
TABLE 248 CHINA: WEIGHT MONITORING DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 264
TABLE 249 CHINA: PATIENT MONITORING DEVICES MARKET, BY END USER,
2024–2031 (USD MILLION) 265
TABLE 250 INDIA: PATIENT MONITORING DEVICES MARKET, BY PRODUCT,
2024–2031 (USD MILLION) 266
TABLE 251 INDIA: BLOOD GLUCOSE MONITORING DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 267
TABLE 252 INDIA: CARDIAC MONITORING DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 267
TABLE 253 INDIA: MULTIPARAMETER MONITORING DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 268
TABLE 254 INDIA: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 268
TABLE 255 INDIA: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 269
TABLE 256 INDIA: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 269
TABLE 257 INDIA: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 270
TABLE 258 INDIA: NEUROMONITORING DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 270
TABLE 259 INDIA: WEIGHT MONITORING DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 271
TABLE 260 INDIA: PATIENT MONITORING DEVICES MARKET, BY END USER,
2024–2031 (USD MILLION) 271
TABLE 261 AUSTRALIA: PATIENT MONITORING DEVICES MARKET, BY PRODUCT,
2024–2031 (USD MILLION) 272
TABLE 262 AUSTRALIA: BLOOD GLUCOSE MONITORING DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 272
TABLE 263 AUSTRALIA: CARDIAC MONITORING DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 273
TABLE 264 AUSTRALIA: MULTIPARAMETER MONITORING DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 273
TABLE 265 AUSTRALIA: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 274
TABLE 266 AUSTRALIA: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 274
TABLE 267 AUSTRALIA: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 275
TABLE 268 AUSTRALIA: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 275
TABLE 269 AUSTRALIA: NEUROMONITORING DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 276
TABLE 270 AUSTRALIA: WEIGHT MONITORING DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 276
TABLE 271 AUSTRALIA: PATIENT MONITORING DEVICES MARKET, BY END USER,
2024–2031 (USD MILLION) 277
TABLE 272 SOUTH KOREA: PATIENT MONITORING DEVICES MARKET, BY PRODUCT,
2024–2031 (USD MILLION) 278
TABLE 273 SOUTH KOREA: BLOOD GLUCOSE MONITORING DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 278
TABLE 274 SOUTH KOREA: CARDIAC MONITORING DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 279
TABLE 275 SOUTH KOREA: MULTIPARAMETER MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 279
TABLE 276 SOUTH KOREA: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 280
TABLE 277 SOUTH KOREA: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 280
TABLE 278 SOUTH KOREA: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET,
BY TYPE, 2024–2031 (USD MILLION) 281
TABLE 279 SOUTH KOREA: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 281
TABLE 280 SOUTH KOREA: NEUROMONITORING DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 282
TABLE 281 SOUTH KOREA: WEIGHT MONITORING DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 282
TABLE 282 SOUTH KOREA: PATIENT MONITORING DEVICES MARKET, BY END USER,
2024–2031 (USD MILLION) 283
TABLE 283 REST OF ASIA PACIFIC: PATIENT MONITORING DEVICES MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 284
TABLE 284 REST OF ASIA PACIFIC: BLOOD GLUCOSE MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 285
TABLE 285 REST OF ASIA PACIFIC: CARDIAC MONITORING DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 285
TABLE 286 REST OF ASIA PACIFIC: MULTIPARAMETER MONITORING DEVICES MARKET,
BY TYPE, 2024–2031 (USD MILLION) 286
TABLE 287 REST OF ASIA PACIFIC: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 286
TABLE 288 REST OF ASIA PACIFIC: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 287
TABLE 289 REST OF ASIA PACIFIC: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 287
TABLE 290 REST OF ASIA PACIFIC: FETAL & NEONATAL MONITORING DEVICES MARKET,
BY TYPE, 2024–2031 (USD MILLION) 288
TABLE 291 REST OF ASIA PACIFIC: NEUROMONITORING DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 288
TABLE 292 REST OF ASIA PACIFIC: WEIGHT MONITORING DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 289
TABLE 293 REST OF ASIA PACIFIC: PATIENT MONITORING DEVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 289
TABLE 294 LATIN AMERICA: PATIENT MONITORING DEVICES MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 290
TABLE 295 LATIN AMERICA: PATIENT MONITORING DEVICES MARKET, BY PRODUCT,
2024–2031 (USD MILLION) 291
TABLE 296 LATIN AMERICA: BLOOD GLUCOSE MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 291
TABLE 297 LATIN AMERICA: CARDIAC MONITORING DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 292
TABLE 298 LATIN AMERICA: MULTIPARAMETER MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 292
TABLE 299 LATIN AMERICA: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 293
TABLE 300 LATIN AMERICA: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 293
TABLE 301 LATIN AMERICA: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET,
BY TYPE, 2024–2031 (USD MILLION) 294
TABLE 302 LATIN AMERICA: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 294
TABLE 303 LATIN AMERICA: NEUROMONITORING DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 295
TABLE 304 LATIN AMERICA: WEIGHT MONITORING DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 295
TABLE 305 LATIN AMERICA: PATIENT MONITORING DEVICES MARKET, BY END USER,
2024–2031 (USD MILLION) 296
TABLE 306 BRAZIL: PATIENT MONITORING DEVICES MARKET, BY PRODUCT,
2024–2031 (USD MILLION) 297
TABLE 307 BRAZIL: BLOOD GLUCOSE MONITORING DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 298
TABLE 308 BRAZIL: CARDIAC MONITORING DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 298
TABLE 309 BRAZIL: MULTIPARAMETER MONITORING DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 299
TABLE 310 BRAZIL: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 299
TABLE 311 BRAZIL: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 300
TABLE 312 BRAZIL: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 300
TABLE 313 BRAZIL: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 301
TABLE 314 BRAZIL: NEUROMONITORING DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 301
TABLE 315 BRAZIL: WEIGHT MONITORING DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 301
TABLE 316 BRAZIL: PATIENT MONITORING DEVICES MARKET, BY END USER,
2024–2031 (USD MILLION) 302
TABLE 317 MEXICO: PATIENT MONITORING DEVICES MARKET, BY PRODUCT,
2024–2031 (USD MILLION) 303
TABLE 318 MEXICO: BLOOD GLUCOSE MONITORING DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 303
TABLE 319 MEXICO: CARDIAC MONITORING DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 304
TABLE 320 MEXICO: MULTIPARAMETER MONITORING DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 304
TABLE 321 MEXICO: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 305
TABLE 322 MEXICO: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 305
TABLE 323 MEXICO: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 306
TABLE 324 MEXICO: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 306
TABLE 325 MEXICO: NEUROMONITORING DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 307
TABLE 326 MEXICO: WEIGHT MONITORING DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 307
TABLE 327 MEXICO: PATIENT MONITORING DEVICES MARKET, BY END USER,
2024–2031 (USD MILLION) 308
TABLE 328 REST OF LATIN AMERICA: PATIENT MONITORING DEVICES MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 309
TABLE 329 REST OF LATIN AMERICA: BLOOD GLUCOSE MONITORING DEVICES MARKET,
BY TYPE, 2024–2031 (USD MILLION) 310
TABLE 330 REST OF LATIN AMERICA: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 310
TABLE 331 REST OF LATIN AMERICA: MULTIPARAMETER MONITORING DEVICES MARKET,
BY TYPE, 2024–2031 (USD MILLION) 311
TABLE 332 REST OF LATIN AMERICA: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 311
TABLE 333 REST OF LATIN AMERICA: TEMPERATURE MONITORING DEVICES MARKET,
BY TYPE, 2024–2031 (USD MILLION) 312
TABLE 334 REST OF LATIN AMERICA: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 312
TABLE 335 REST O